LONG-TERM SURVIVAL IN ACUTE MYELOID-LEUKEMIA - THE-EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE

被引：38
作者：
BENNETT, JM
ANDERSEN, JW
CASSILETH, PA
机构：
[1] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642
[2] HARVARD UNIV,SCH PUBL HLTH,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115
[3] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104
[4] HOSP UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104
来源：
LEUKEMIA RESEARCH | 1991年 / 15卷 / 04期
关键词：
PROMYELOCYTIC LEUKEMIA; CURABILITY OF LEUKEMIA;
D O I：
10.1016/0145-2126(91)90124-C
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A retrospective analysis of two ECOG adult AML trials conducted from 1976 to 1983 was carried out focusing on long term disease-free survival. This report summarizes the data on 545 patients with a minimum follow up of 7 1/2 years. The complete remission rate was 57% with an estimated cure rate of 12%. Of several prognostic variables examined only FAB type M3 (promyelocytic leukemia) was statistically significant (estimated cure rate of 33% vs 9% for other FAB subtypes).
引用
收藏
页码：223 / 227
页数：5
相关论文
共 23 条
123